Hao Duan Selected Research

Glioma (Gliomas)

10/2023	IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma.
6/2023	Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
1/2023	PERK-Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti-Tumoral Polarization of Microglia.
1/2022	High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?
1/2021	CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.
1/2021	Prognostic value of modified systemic inflammatory score in patients with newly diagnosed high-grade gliomas.
1/2021	CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.
1/2021	Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme.
11/2019	Pretreatment neutrophil-to-lymphocyte ratio plus albumin-to-gamma-glutamyl transferase ratio predict the diagnosis of grade III glioma.
7/2017	Evaluation of cumulative prognostic score based on pretreatment plasma fibrinogen and serum albumin levels in patients with newly diagnosed high-grade gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hao Duan Research Topics

Disease

18	Neoplasms (Cancer) 06/2023 - 06/2014
10	Glioma (Gliomas) 10/2023 - 07/2017
7	Glioblastoma (Glioblastoma Multiforme) 06/2023 - 01/2018
4	Brain Neoplasms (Brain Tumor) 04/2023 - 09/2018
3	Neoplasm Metastasis (Metastasis) 01/2024 - 05/2016
3	Lung Neoplasms (Lung Cancer) 04/2023 - 06/2022
3	Ischemic Stroke 04/2017 - 03/2010
3	Esophageal Squamous Cell Carcinoma 12/2016 - 11/2015
2	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2018
2	Asthenopia (Eyestrain) 06/2023 - 04/2023
2	Inflammation (Inflammations) 06/2023 - 05/2016
2	Osteoporosis 01/2022 - 12/2021
2	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 11/2016 - 06/2014
2	Stroke (Strokes) 01/2012 - 03/2010
1	Neuroinflammatory Diseases 05/2024
1	Postpartum Depression (Post-Natal Depression) 05/2024
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2024
1	Alzheimer Disease (Alzheimer's Disease) 10/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2023
1	Fatigue 05/2023
1	Constipation 05/2023
1	Heart Failure 04/2023
1	Glycosuria 04/2023
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2023
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2023
1	Infections 01/2023
1	Medulloblastoma 07/2022
1	Postoperative Nausea and Vomiting (PONV) 06/2022
1	Vascular Remodeling 12/2021
1	Postmenopausal Osteoporosis 12/2021
1	Hallux Valgus 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
4	RNA (Ribonucleic Acid)IBA 08/2022 - 01/2021
3	AlbuminsIBA 01/2021 - 07/2017
3	DNA (Deoxyribonucleic Acid)IBA 06/2020 - 01/2012
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2023 - 06/2014
2	HydrogelsIBA 08/2022 - 06/2022
2	Fluorescein (Funduscein)FDA LinkGeneric 07/2022 - 09/2018
2	C-Reactive ProteinIBA 01/2021 - 05/2016
2	Fibrinogen (Factor I)FDA Link 01/2021 - 07/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2018
2	Serum AlbuminIBA 07/2017 - 05/2016
1	Tuberculin (PPD)IBA 05/2024
1	Antiviral Agents (Antivirals)IBA 10/2023
1	InterferonsIBA 10/2023
1	Amyloid (Amyloid Fibrils)IBA 10/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2023
1	OilsIBA 06/2023
1	Hematoxylin (Haematoxylon)IBA 06/2023
1	xihuangIBA 06/2023
1	Sincalide FDA Link 06/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2023
1	AntioxidantsIBA 05/2023
1	Taurine FDA Link 04/2023
1	empagliflozinIBA 04/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2023
1	Glucose (Dextrose)FDA LinkGeneric 04/2023
1	Sodium-Glucose Transport ProteinsIBA 04/2023
1	EpitopesIBA 01/2023
1	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 01/2023
1	PAM2-CSK4IBA 01/2023
1	CholesterolIBA 01/2023
1	LipopeptidesIBA 01/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2023
1	Apolipoproteins E (ApoE)IBA 01/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	Pattern Recognition ReceptorsIBA 01/2023
1	Secretory Immunoglobulin A (SIgA)IBA 01/2023
1	NLR ProteinsIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	CytokinesIBA 01/2023
1	VaccinesIBA 01/2023
1	PolymersIBA 08/2022
1	matrigelIBA 08/2022
1	dolasetron (Anzemet)FDA Link 06/2022
1	Analgesics (Analgesic Drugs)IBA 06/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Enhancer RNAsIBA 01/2021
1	17- N,N- diethylcarbamoyl- 4- methyl- 4- azaandrostane- 3- one (DMAA)IBA 01/2021
1	Combined Antibody TherapeuticsIBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 06/2020
1	Circulating Tumor DNAIBA 06/2020
1	NF-kappa B (NF-kB)IBA 01/2020

Therapy/Procedure

10	Therapeutics 06/2023 - 06/2014
3	Immunotherapy 01/2022 - 01/2021
2	Contraindications 04/2023 - 03/2010
2	Radiotherapy 01/2023 - 01/2018
2	Ovariectomy (Oophorectomy) 01/2022 - 12/2021
2	Operative Surgical Procedures 01/2019 - 09/2018
1	Precision Medicine 04/2024
1	Oncolytic Virotherapy 10/2023
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2023
1	Thoracotomy 06/2022
1	Molecular Targeted Therapy 01/2022
1	Transplantation 01/2022
1	Lasers (Laser) 12/2021
1	Drug Therapy (Chemotherapy) 06/2020